Literature DB >> 22298223

Focal therapy of prostate cancer: evidence-based analysis for modern selection criteria.

Michael R Abern1, Matvey Tsivian, Thomas J Polascik.   

Abstract

Focal therapy for prostate cancer has been increasingly utilized with the goal of effective disease control while maximizing patient functional outcomes. The optimal patient selection criteria are not known and therefore are not standardized. This review compares the available expert panel consensus guidelines with the selection criteria utilized in recently published focal therapy trials. Because the data from focal trials are still maturing, the currently enrolling clinical trials are reviewed as well. In addition, the recent literature regarding technological advances in prostate biopsy and imaging strategies are added to the current guidelines to recommend a rationale for patient selection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22298223     DOI: 10.1007/s11934-012-0241-5

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  60 in total

1.  Impact of immediate TRUS rebiopsy in a patient cohort considering active surveillance for favorable risk prostate cancer.

Authors:  Andre C King; Andrew Livermore; Timo A J Laurila; Wei Huang; David F Jarrard
Journal:  Urol Oncol       Date:  2011-08-03       Impact factor: 3.498

2.  The optimal rebiopsy prostatic scheme depends on patient clinical characteristics: results of a recursive partitioning analysis based on a 24-core systematic scheme.

Authors:  Vincenzo Scattoni; Marco Raber; Umberto Capitanio; Firas Abdollah; Marco Roscigno; Diego Angiolilli; Carmen Maccagnano; Andrea Gallina; Antonio Saccà; Massimo Freschi; Claudio Doglioni; Patrizio Rigatti; Francesco Montorsi
Journal:  Eur Urol       Date:  2011-07-30       Impact factor: 20.096

3.  The role of transrectal saturation biopsy in tumour localization: pathological correlation after retropubic radical prostatectomy and implication for focal ablative therapy.

Authors:  Firas Abdollah; Vincenzo Scattoni; Marco Raber; Marco Roscigno; Alberto Briganti; Nazareno Suardi; Andrea Gallina; Umberto Capitanio; Massimo Freschi; Andrea Salonia; Andrea Cestari; Giorgio Guazzoni; Patrizio Rigatti; Francesco Montorsi
Journal:  BJU Int       Date:  2010-11-19       Impact factor: 5.588

4.  Characterizing stiffness of human prostates using acoustic radiation force.

Authors:  Liang Zhai; John Madden; Wen-Chi Foo; Vladimir Mouraviev; Thomas J Polascik; Mark L Palmeri; Kathryn R Nightingale
Journal:  Ultrason Imaging       Date:  2010-10       Impact factor: 1.578

5.  Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging.

Authors:  Peter A Pinto; Paul H Chung; Ardeshir R Rastinehad; Angelo A Baccala; Jochen Kruecker; Compton J Benjamin; Sheng Xu; Pingkun Yan; Samuel Kadoury; Celene Chua; Julia K Locklin; Baris Turkbey; Joanna H Shih; Stacey P Gates; Carey Buckner; Gennady Bratslavsky; W Marston Linehan; Neil D Glossop; Peter L Choyke; Bradford J Wood
Journal:  J Urol       Date:  2011-08-17       Impact factor: 7.450

6.  The index lesion and focal therapy: an analysis of the pathological characteristics of prostate cancer.

Authors:  Simon R J Bott; Hashim U Ahmed; Richard G Hindley; Ahmad Abdul-Rahman; Alex Freeman; Mark Emberton
Journal:  BJU Int       Date:  2010-12       Impact factor: 5.588

7.  Accuracy of 3-Tesla magnetic resonance imaging for the staging of prostate cancer in comparison to the Partin tables.

Authors:  H Augustin; G A Fritz; T Ehammer; M Auprich; K Pummer
Journal:  Acta Radiol       Date:  2009-06       Impact factor: 1.990

8.  Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?

Authors:  Jennifer R Stark; Sven Perner; Meir J Stampfer; Jennifer A Sinnott; Stephen Finn; Anna S Eisenstein; Jing Ma; Michelangelo Fiorentino; Tobias Kurth; Massimo Loda; Edward L Giovannucci; Mark A Rubin; Lorelei A Mucci
Journal:  J Clin Oncol       Date:  2009-05-11       Impact factor: 44.544

9.  Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer: initial results.

Authors:  David S Ellis; Theodore B Manny; John C Rewcastle
Journal:  Urology       Date:  2007-12       Impact factor: 2.649

10.  Multi-parametric magnetic resonance imaging to rule-in and rule-out clinically important prostate cancer in men at risk: a cohort study.

Authors:  Paul Rouse; Greg Shaw; Hashim U Ahmed; Alex Freeman; Clare Allen; Mark Emberton
Journal:  Urol Int       Date:  2011-06-22       Impact factor: 2.089

View more
  5 in total

1.  Cryosurgery, an alternative treatment option for organ-confined prostate cancer: current beliefs and practice patterns of urologists.

Authors:  Michael Kongnyuy; Daniel M Halpern; Kaitlin E Kosinski; Aaron E Katz
Journal:  Int Urol Nephrol       Date:  2016-10-19       Impact factor: 2.370

Review 2.  Mechanisms of cryoablation: clinical consequences on malignant tumors.

Authors:  J G Baust; A A Gage; T E Bjerklund Johansen; J M Baust
Journal:  Cryobiology       Date:  2013-11-13       Impact factor: 2.487

Review 3.  Current status of cryotherapy for prostate and kidney cancer.

Authors:  Seok Cho; Seok Ho Kang
Journal:  Korean J Urol       Date:  2014-11-21

4.  The tumor volume after radical prostatectomy and its clinical impact on the prognosis of patients with localized prostate cancer.

Authors:  Hyeong Dong Yuk; Seok-Soo Byun; Sung Kyu Hong; Hakmin Lee
Journal:  Sci Rep       Date:  2022-04-09       Impact factor: 4.379

5.  Refining treatment for the men who need it: lessons from the PIVOT trial.

Authors:  Michael R Abern; Matvey Tsivian; Thomas J Polascik
Journal:  Transl Androl Urol       Date:  2013-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.